MSP008-22 is a new drug candidate that shows excellent efficacy against a range of viruses during preclinical development MUMBAI, India, Aug. 9, 2023 /PRNewswire/ — Sathgen Therapeutics, a division of the leading chemicals conglomerate in India – Godavari Biorefineries Limited (GBL),…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.